Quarterly demat and remat compliance certificate to exchanges

Compliance View source PDF Explain this filing

TARSONS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.6%Reaction day

₹320.30

prior close

₹324.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+2.7% vs market

Medical Equipment & Supplies peers, median of 13sector-1.3%+4.9% vs sector

On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250 and 4.9 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

-0.3

15m

+1.8

30m

+3.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.6+0.8+2.7-1.3+4.9

Next day

+5.8+1.0+4.8-1.0+6.8

+4.7+1.7+2.9-2.0+6.7

+2.2+0.1+2.2-2.7+5.0

+3.6+0.8+2.9-2.4+6.0

-1.9-0.9-1.0-2.6+0.8

-4.4-4.5+0.1-8.0+3.6

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Tarsons Products has submitted a routine quarterly certificate to BSE and NSE, confirming that its registrar KFin Technologies filed the required demat and remat details for the quarter ending September 30, 2026 with both depositories NSDL and CDSL and the stock exchanges. This is a standard SEBI Regulation 74(5) compliance filing with no business impact.

Likely market impact

Routine compliance filing; no material impact on shareholders or stock price.